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ABSTRACT
The limitation of self-repair and proliferation capacity of chondrocytes in cartilage reconstruction lead to alternative 
search of cell source that can improve the auricular regeneration. Human adipose-derived stem cells (HADSC) are an 
alternative cell source that have unique characteristics to self-renew and differentiate into various tissues making it 
suitable for cell therapy and tissue engineering. This study aimed to examine the chondrogenic differentiation potential of 
(HADSC) in monolayer culture by the presence of different transforming growth factor beta’s, TFG-β1, -β2 and -β3. HADSC 
at passage 3 (1.5 × 105 cell/mL) were cultured in chondrogenic medium containing 5 ng/mL of different transforming 
growth factor beta’s, TFG-β1, -β2 and -β3 for 7, 14 and 21 days. Data analysis was evaluated based on the growth 
rate of cells, cells morphological changed, production of collagen type II and glycosaminoglycan sulphate (sGAG). The 
quantitative RT-PCR was carried out to determine the chondrogenic, fibrogenic and hypertrophic gene expression levels. 
Differentiation of HADSC into chondrocytes using TFG-β indicates the occurrence of the chondrogenesis process. The best 
chondrogenic differentiation was observed in HADSC induced by TFG-β3 through the chondrocytes-like cells morphology 
with cells aggregation and high production of proteoglycan matrices compared to other TGF-βs groups. Additionally, 
the expression of chondrocytes-specific genes such as Type II collagen, Aggrecan core protein, Elastin and Sox 9 was 
high. In conclusion, this study has showed that TGF-β3 is the potential growth factor in producing chondrogenic cells 
for auricular cartilage tissue engineering.
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ABSTRAK
Kekurangan kapasiti pembaikan dan proliferasi kondrosit dalam pembentukan semula tisu rawan menyebabkan 
penyelidikan kini cenderung untuk mencari sumber sel baru yang dapat membantu memperbaiki tisu rawan aurikul 
dengan lebih baik. Sel stem adipos manusia (HADSC) dilihat sebagai sumber sel yang mempunyai ciri-ciri unik, boleh 
membahagi dengan sendiri dan membeza kepada pelbagai tisu, menyebabkan ia sesuai digunakan dalam terapi sel dan 
kejuruteraan tisu. Kajian ini bertujuan menilai tahap pembezaan kondrogeniknya secara monolapisan kultur dengan 
kehadiran faktor pertumbuhan transformasi beta yang berbeza iaitu TFG-β1,-β2 dan -β3. HADSC pada pasaj 3 (1.5 105 
sel/mL) dikultur di dalam media kondrogenik yang mengandungi 5 ng/mL faktor pertumbuhan transformasi beta yang 
berbeza iaitu TFG-β1,-β2 dan -β3 selama 7, 14 dan 21 hari. Analisis data dinilai berdasarkan kepada kadar pertumbuhan 
sel, perubahan morfologi sel, pengeluaran kolagen jenis II dan glikoaminoglikan fosfat (sGAG). Kuantitatif RT-PCR 
dijalankan untuk menentukan kadar ekspresi gen kondrogenik, fibrogenik dan hipertrofik. Pembezaan HADSC kepada 
kondrosit menggunakan TFG-β menunjukkan berlakunya proses kondrogenesis. Pembezaan kondrogenik yang terbaik 
dilihat pada HADSC yang diaruhkan oleh TFG-β3 melalui perubahan morfologi dengan pembentukan sel agregasi dan 
penghasilan matrik proteoglikan yang tinggi apabila dibandingkan dengan kumpulan TFG-β yang lain. Tambahan pula, 
pengekspresan gen spesifik kondrogenik iaitu Kolagen jenis II, Elastin, Protien teras agrekan dan Sox 9 menunjukkan 
peningkatan. Kesimpulannya, kajian ini telah menunjukkan TFG-β3 berpotensi sebagai faktor pertumbuhan yang berupaya 
membantu penghasilan sel yang bercirikan kondrosit aurikular bagi strategi kejuruteraan tisu rawan aurikular.
Kata kunci: Aruhan; kondrosit; pembezaan kondrogenik; sel stem adipos manusia; tgf-β3
INTRODUCTION
Congenital or acquired deformities of the external ear 
have significant negative impact on patients. This defect 
also involves the formation of abnormal or absent of 
duct connects to the middle ear (Luquetti et al. 2012). At 
present, the most commonly used treatment for deformities 
of the external ear is the ear-shaped prosthetics or hand-
carved autologous costal cartilage graft (Cho et al. 2007). 
The harvesting of costal cartilage procedure causes the 
morbidity at the donor site and has a risk of infection 
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after the surgery (Ishak et al. 2011; Zhang et al. 2014). 
The use of prosthetic ear has complication on extrusion of 
the plastic synthetic graft (Ishak et al. 2015). Hence, the 
development of alternative ear construct is needed to treat 
the defect by improving the clinical outcome of external 
ear reconstruction (Ruszymah et al. 2007).
 In order to solve these problems, tissue engineering 
has been introduced. In recent years, tissue engineering has 
given a good development in the treatment of external ear 
defect in which the formation of new cartilage is produced 
in vitro and in vivo (Hohman et al. 2014). However, there is 
a limitation to this process because of the large amount of 
chondrocytes needed to form the human size external ear 
cartilage in a given time. Previous studies have found that 
the characteristic of chondrocytes will gradually disappear 
when chondrocytes were cultured in 2D culture flasks in 
vitro for too long (Kamil et al. 2003). Thus, stem cells with 
high renewability and chondrogenic ability are targeted as a 
new alternative cell source for cartilage tissue engineering.
 Human adipose-derived stem cells (HADSC) are 
mesenchymal stem cells that are potent in regenerative 
medicine and tissue engineering fields. HADSC are easily 
acquired and isolated from fatty tissue (Hui et al. 2012; 
Zhao et al. 2012). Additionally, HADSC have multi potency 
characteristics, especially in chondrogenic differentiation 
capabilities that are similar to bone marrow stem cells (De 
Ugarte et al. 2003). However, differentiation of HADSC 
into the chondrocytes is dependent on the appropriate 
biological and micro-environmental signals. Therefore, 
to produce cartilage from HADSC, factors such as media, 
matrix composition, chondrogenic differentiation factors, 
oxygen tension and mechanical environment need to be 
determined. Additionally, the factors that affect the process 
of the chondrogenesis in stem cells are still unclear.
 Generally, members of transformation growth factors 
and additional growth factors or hormones such as Fetal 
Bovine Serum (FBS), Insulin-Transferrin- Selenium (ITS), 
ascorbic acid, Insulin-like Growth Factor-1 (IGF-1) and 
dexamethasone were used in chondrogenic induction 
media which could affects chondrogenic growth and 
differentiation in stem cells (Hamid et al. 2012). Previous 
studies have shown that additional growth factors such as 
FBS can stimulated cell growth because it contains many 
growth factors, cytokines and peptides that show significant 
diversity (Awad et al. 2003). The additional growth factor 
such as ITS is a serum replacement that reduces the variety 
of serum variation in growth and cell differences (Chua et 
al. 2005) and prevents the differentiation of monoculture 
(Liu et al. 2014). In addition, ascorbic acid plays a role in 
modulating the growth and diffusion of cells by stimulating 
monolayer culture cell proliferation and enhancing the 
type of collagen genes expression in a short period of 
time (Awad et al. 2003). The IGF-1 factor is believed to 
enhance the effect of TGF-β3 on chondrogenic induction 
and its involved in regulatory metabolism (Zhou et al. 
2016). Meanwhile, dexamethasone also plays a role in 
the process of stem cell chondrogenic by promoting 
differentiation into chondrocytes. Meanwhile, previous 
studies have also shown that the members of transformation 
growth factors comprising various peptide isomers which 
play a role in controlling the development of the process 
of the chondrogenesis (Awad et al. 2003). However, the 
role of each members of transformation growth factor in 
modulating the process of chondrogenesis is still unclear.
 This study focuses on one of the factors mentioned 
previously which is the inductive growth factor added in 
the chondrogenic medium to induce HADSC differentiation. 
The beta-growth factor (TGF-β) consisting of TGF-β1, 
TGF-β2 and TGF-β3 is one of the growth factors widely 
used in the mesenchymal stem cell chondrogenic process 
(Crecente-Campo et al. 2017). However, each TGF-β 
showed different effects on chondrogenesis on stem cells in 
terms of regulatory control, cell viability/proliferation, cell 
differentiation and extracellular matrix production. Hence, 
this study hypothesised that human adipose stem cells 
have differentiating capabilities to chondroblast with the 
presence of secondary family transformation growth factors 
in the chondrogenic media and each TGF-β has a special 
regulatory effect in chondrogenic process of stem cells.
MATERIALS AND METHODS
ETHICAL APPROVAL
The ethical approval to use HADSC in this study was 
obtained from the Research and Ethics Committee of 
Universiti kebangsaan Malaysia Medical Centre (Approval 
code of 02-01-02-SF0976). All samples used in this study 
were accompanied with informed consent from patients at 
Universiti Kebangsaan Malaysia. 
ISOLATION OF HUMAN ADIPOSE DERIVED                            
STEM CELLS (HADSC)
Briefly, human adipose sample from caesarean operation 
was minced into small pieces and washed with PBS 
containing 1% of antibiotic/antimycotic solution (Gibco, 
USA). The sample was digested using 0.3% collagenase type 
I (Worthinghon, USA) at 37°C for 30 min. After digestion, 
the pelleted cells were re-suspended in DMEM medium 
containing 10% fetal bovine serum (FBS; Invitrogen), 1% 
antibiotic-antimycotic (Gibco-Invitrogen), 1% glutamax 
(Gibco- Invitrogen), 1% vitamin C (Sigma-Aldrich, St 
Louis, MO) and incubated at 37°C with 5% CO2. Once the 
cultured cells reached 80 to 90% confluency, cells were 
detached with 0.125% trypsin-EDTA and passaged. Cells at 
passage 3-4 were used for subsequent experiments.
CHONDROGENIC DIFFERENTIATION OF HUMAN ADIPOSE 
DERIVED STEM CELLS
Cell culture at passage 3 which reached 80% confluency 
was trypsinized using trypsin EDTA 0.125% (TE). A total 
of 1.5 × 105 cells/mL was suspended in a chondrogenic 
induction medium containing either 5 ng/mL of TGF-Beta 
1 or TGF-Beta 2 or TGF-Beta 3 and cultured into a six 
well plate. Cells were incubated in 5% CO2 incubator at 
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37ºC for three weeks. Medium was changed every three 
days. The cultured cells were assessed for growth rate, 
immunocytochemistry staining, sGAG and qRT-PCR.
GROWTH RATE
Cell morphology changes were evaluated using light 
inverted microscope at the first, second and third weeks. 
Cells were cultured in six wells plate with a cell density of 
150,000 cells per well over three weeks. The cell growth 
was measured at first, second and third week using Alamar 
Blue assay. A total of 100 μL Alamar Blue reagents was 
added to each well containing 1000 μL medium culture 
with a ratio of 1:10 and incubated for 4 h at 37ºC in 5% CO2 
incubator under dark condition. After 4 h of incubation, 
100 uL of the treated medium was dispended into each well 
on the 96-wells plate. The value of the absorbance of each 
well was read at the wavelength of 570 nm. 
IMMUNOCYTOCHEMISTRY STAINING
Cultured cells were rinsed using PBS × 1 three times before 
being fixed with 4% paraformaldehyde solution for 1 h at 
4ºC. The cells were then rinsed with PBS × 1 cold-tempered 
twice. Subsequently, the cells were treated with Triton 
X-100 0.1% solution for 5 min and rinsed using Tween 20 
0.1% solution. Cells were blocked using 10% goat goats 
for 1 h at 37ºC in dark condition. The primary antibody 
solution was added to the well and incubated overnight at 
4ºC. After that, cells were washed using Tween 20 0.1% 
solution, PBS × 1 for 10 min each. The cells were then 
rinsed using 1% goat serum and secondary antibodies were 
added to the well. Cells were incubated for 2 h at 37ºC. 
After that, the cells were washed using a Tween 20 0.1% 
solution and PBS × 1 for 5 min each. The staining of the 
nucleus was continued by adding a solution for nucleus 
staining and incubated at room temperature for 20 min. 
Subsequently, the cells were washed using PBS × 1 and 
wrapped in aluminium foil to prevent exposure to light 
until observed under a light microscope.
sGAG AND DNA ANALYSES
The samples were digested using digestion buffer and 
proteinase K under occasional vortexing at 55°C. The 
digested samples were assayed for DNA content using 
PureLink Genomic® DNA kits (Invitrogen, UK) according 
to the manufacture’s instruction. Measurements were 
made at 535 nm. Proteoglycan content was determined by 
quantifying the amount of sulphated glycosaminoglycans 
(sGAG) in samples using the Blyscan Kit (Biocolor, UK) 
according to the manufacturers’ instructions. Measurements 
were made at 656 nm. The standard curve was generated 
with bovine trachea chondroitin sulfate A. 
QUANTITATIVE GENE EXPRESSION BY REAL-TIME PCR
Total RNA of samples were extracted using TRI reagent 
(Molecular Research Centre, Cincinnati, OH) and 
subsequent synthesis of cDNA with an Invitrogen 
SuperScript III First-Strand cDNA kit (Invitrogen) 
according to the manufacturer’s instructions. Real-time PCR 
reaction was performed with SYBR Green fluorescent dye 
(SYBR Select Master Mix, Applied Biosystems) according 
to the manufacturer’s recommendation. The real-time PCR 
reactions were carried out with pre-denaturation at 95°C 
for 3 min, followed by 40 cycles of denaturation with 
10 s at 95°C, annealing and extension for 30 s at 61°C 
using Bio-rad iCycler. The PCR cycles were followed by 
a melting curve analysis to determine the specificity of 
the PCR products. The expression level of each targeted 
gene was normalized to glyceralde- hyde-3-phosphate-
dehydrogenase gene (GAPDH) and was then calculated for 
statistical analysis. The primer sequences for collagen type 
II, elastin, aggrecan core protein, and sox9 were listed in 
Table 1. Primers were chosen from GeneBank data base 
sequences corresponding to the specific gene Accession 
Number, according to previously described (Goh et al. 
2017).
STATISTICAL ANALYSIS
Data were assessed as mean± SEM (standard error of the 
mean). Obtained results were analysed using Student’s 
t-test using SPSS 20.0 (SPSS Inc., Chicago) and P values < 
0.05 were considered significant.
RESULTS AND DISCUSSION
EFFECT OF TGF-ΒS ON GROWTH RATE AND            
MORPHOLOGY OF HADSC
Figure 1 shows the total cell number of HADSC induced 
with TGF-β1, -β2 and -β3. The total cell number was not 
significantly difference in TGF-β3 when day 21 compared 
to day 7 and day 14. In TGF-β1 induced group, the total cell 
number on day 14 and day 21 was significantly (p<0.05) 
increase compared to day 7. The HADSC induced with 
TGF-β2 showed significant (p<0.05) higher cells number 
on day 14 compared to day 7 and day 21. In contrast, 
the total cell number of HADSC control group (HAD) was 
significantly (p<0.05) increased on day 21. However, the 
total number of cells in human auricular chondrocyte 
control group (NAU) showed no significant difference 
on day 14 compared to day 7. The cell morphology in 
each groups were showed in Figure 2. HADSC control 
group (HAD) showed no morphological changes with 
fibroblastic feature throughout 3 weeks culture. Whereas, 
the human auricular chondrocyte control (NAU) showed 
polygonal cells feature and began to show chondrogenic 
cell aggregation from day 7. Chondrogenic cell aggregation 
was also demonstrated in groups induced with TGF-β1 and 
β3. During the first 7 day culture, HADSC induced with 
TGF-β1 and β3 from fibroblastic feature transformed into 
polygonal shape and cells started to aggregate together. 
Cell aggregation was increased and formed large cell 
clumps with longer culture period (day 14 and day 21). 
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FIGURE 1. The total cell number of HADSC induced with TGF-β1, TGF-β2 and TGF-β3 on day 
7, 14 and 21. HADSC (HAD) and human auricular chondrocyte (NAU) shown as control groups. 
Symbols * denote significant differences between culturing days in each group (p<0.05). 
The value showed mean ± SEM, n=6
FIGURE 2. The morphological changes of HADSC induced with TGF-β1, TGF-β2 and TGF-β3 on day 7, 14 
and 21. HADSC (HAD) and human auricular chondrocyte (NAU) shown as control groups. 
The (↑) sign indicates cell aggregation (100× magnification)
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While, HADSC induced with TGF-β2 did not show cell 
aggregation, the cells remained fibroblastic feature till 
day 21 culture.
 Our finding suggested that cell aggregation was 
the initial sign of chondrogenesis process. This happen 
only in HADSC induced with medium containing TGF-β3 
or TGF-β1. In consistent with previous studies, the 
fibroblastic stem cell morphology was transformed to 
polygonal shape and started cell aggregation before 
the cartilage extracellular matrix was deposited in the 
tissue (Wilson et al. 2011). After cell aggregation, the 
adhesion molecules on the surface of cells decreases as 
the cells soon apart from each other by the production 
of extracellular matrix with continuation of the 
differentiation process (Puetzer et al. 2010). Our results 
were also reported in other studies that cell aggregation 
was observed in human mesenchymal stem cells at day 
14 in the chondrogenic medium containing TGF-β1 and 
dexamethasone (Indrawattana et al. 2004). Study by 
Indrawattana et al. (2004) reported that chondogenesis 
in human mesenchymal stem cells was better and faster 
when induced in chondrogenic medium containing 
TGF-β3, IGF-1 and BMP (Puetzer et al. 2010).
EFFECT OF TGF-ΒS ON COLLAGEN TYPE II               
PRODUCTION IN HADSC
The production of collagen type II was detected by green-
coloured fluorescent antibodies (Figure 3(A)) and blue 
DAPI staining was used to show the cell nucleus (Figure 
3(B)). Human auricular chondrocyte control group (NAU) 
served as the positive control group for collagen type II 
staining. Based on this immunocytochemistry staining 
result, HADSC induced with TGF-β showed positive 
collagen type II production compared to HADSC control 
(HAD). The collagen type II staining was more intent in 
group induced with TGF-β3 compared to TGF-β1 and 
TGF-β2. The collagen type II staining was positive on 
monolayer cells as well as aggregation. The HADSC 
induced TGF-β1 showed reduce in cells aggregation and 
number at culture on day 21. HADSC induced with TGF-β2 
just demonstrate mild collagen type II staining throughout 
21 days culture. HADSC control group did not showed 
positive staining for collagen type II. 
 The production of collagen type II in HADSC induced 
with TGF-β3 showed more positive compared to HADSC 
induced with TGF-β1 and TGF-β2. This results were 
supported by previous studies that bone marrow stem cells 
and adipose-derived stem cells cultured in chondrogenic 
medium containing TGF-β3 and dexamethasone produced 
more collagen type II compared to medium containing 
TGF-β1 and TGF- β2 (Estes et al. 2006). HADSC induced 
with TGF-β1 shown more intent of collagen type II 
immunostaining on day 14 which was consistent with a 
report by Huang et al. (2016) claimed that the production 
of collagen type II in the hMSC cultured with TGF-β1 was 
higher on day 14 (Barry et al. 2001; Huang et al. 2016).
EFFECT OF TGF-ΒS ON THE PRODUCTION OF 
GLYCOSAMINOGLYCAN PHOSPHATE (SGAG) IN HADSC
In biochemical studies, cell density was determined by total 
DNA content and the amount of GAG phosphate production 
was measured by Blyscan’s assay. The ratio of sGAG/DNA 
was then calculated to measure the amount of cartilaginous 
protein produce per amount of DNA. HADSC control group 
(HAD) showed no significant different of sGAG throughout 
3 weeks culture. HADSC induced with TGF-β3 showed the 
highest sGAG/DNA compared to other groups for culture 
on day 14 and 21. These sGAG/DNA values for HADSC 
induced with TGF-β3 on day 14 and 21 were significantly 
(p<0.05) higher than other groups. This was contributed 
by lower DNA and consistent high synthesis of collagen 
type II throughout 3 weeks culture. However, other groups 
were showed significantly (p<0.05) reduced of sGAG/
DNA value on day 14 and 21. Our findings was supported 
by previous studies that showed the production of GAG 
was lower in hMSC cultured in chondrogenic medium 
containing dexamethasone and TGF-β1 on day 7, 14 and 21 
compared to chondrogenic medium containing TGF-β3 and 
TGF-β2 (Indrawattana et al. 2004). The higher sGAG/DNA 
production in HADSC induced with TGF-β3 suggested that 
TGF-β3 is the best growth factor in stem cell chondrogenic 
differentiation and production of cartilaginous extracellular 
matrix (ECM).
EFFECT OF TGF- ΒS ON THE EXPRESSION OF 
CHONDROGENIC GENE IN HADSC
Quantitative RT-PCR analysis was performed on HADSC 
induced with TGF-βs to assess the level of genes 
expression in HADSC control group (HAD), human auricular 
chondrocyte control group (NAU), HADSC induced with 
TGF-β1, TGF-β2 and TGF-β3 on day 7, 14 and 21 cultures. 
The expression of Type II collagen gene (Figure 5(A)) 
was showed significantly (p<0.05) higher expressed by 
6.0 and 2.7 folds on day 14 compared to day 7 cultures 
in HADSC induced with TGF-β1 and TGF-β2, respectively. 
Meanwhile, Type II collagen gene expression in HADSC 
induced with TGF-β3 was high throughout 3 weeks culture 
and showed no significant difference in various time 
points. However, HADSC induced with TGF-β3 showed 
the highest Type II collagen gene expression compared to 
other groups. For the expression of Elastin (Figure 5(B)), 
gene expression was observed to be significantly (p<0.05) 
increased in HADSC induced with TGF-β1 and TGF-β3 on 
the day 21 culture compared to day 7 and day 14 culture. 
HADSC induced with TGF-β3 was found to exhibit the 
highest Elastin gene expression compared to other groups. 
Meanwhile, Elastin expression in HADSC induced with 
TGF-β2 was moderate throughout 3 weeks culture period. 
Gene expression of Aggrecan core protein was showed 
significantly (p<0.05) increased by 3.0, 11.0 and 7.0 fold 
in the HADSC induced with TGF-β1, TGF-β2 and TGF-β3 
on day 14 compared to day 7 (Figure 5(C)). Additionally, 
HADSC induced with TGF-β3 showed significantly (p<0.05) 
increased in Aggrecan core protein gene expression on day 
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21 of cultures. The highest gene expression also shown in 
HADSC induced with TGF-β3 on day 21 compared to other 
groups. The expression of Sox 9 gene (Figure 5(D)) was 
significantly (p<0.05) higher with 3.5 and 3.3 fold in the 
human chondrocyte control group and HADSC induced 
with TGF-β1 on day 21 compared to the day 14 of culture. 
The HADSC induced with TGF-β3 also exhibited a high 
gene expression with 1.6 fold on day 14 compared to day 
7 of culture. In contrast, the expression gene of Type I 
collagen was significantly (p<0.05) reduced in expression 
by -19.0 and -36.0.0 folds in HADSC induced with TGF-β1 
and TGF-β3 on day 21 compared to day 14. Meanwhile, 
other groups did not show any significant differences in 
the expression of Type I collagen between day 14 and 21 
(Figure 5(E)). Expression on gene Type X collagen in 
HADSC control (HAD), human auricular chondrocyte control 
(NAU) and HADSC induced with TGF-β1 and TGF-β3 were 
showed significantly (p<0.05) decrease in gene expression 
by -1.0, -2.0, -1.8 and -2.5 folds on day 21 compared to 
day 14. Whereas, HADSC induced with TGF-β2 showed 
not significantly decrease in expression on day 21 (Figure 
5(F)). 
 Our data showed that Type II collagen and core 
proteins were expressed HADSC induced by TGF-βs, 
and the expression of Sox 9 gene was occurred when 
the formation of aggregation. This consistent with the 
previous study that reported, Sox 9 gene expression 
during aggregation encourages the expression of Type II 
collagen gene and Aggrecan (Mueller & Tuan 2008). The 
expression of Aggrecan core protein was showed closely 
related to the production of extracellular matrix (ECM), 
especially glycosaminoglycan that shown in the previous 
sGAG analysis. However, the expression of fibroblastic 
gene (Type I collagen) and hypertrophic gene (Type 
X collagen) were seemed high in HADSC induced with 
TGF-βs. These finding suggested that the long induction 
time of stem cells to TGF-βs were affected the variety of 
features and hypertrophy of stem cells (Barry et al. 2001). 
This finding was supported by previous study that hMSC 
cultured in chondrogenic medium containing TGF-β3 was 
FIGURE 4. Biochemical analysis of the production of glycosaminoglycan phosphate (sGAG) for HADSC control (HAD), 
Human auricular chondrocyte control (NAU), HADSC induced with TGF-β1, TGF-β2 and TGF-β3. A) Total DNA content, B) 
Total GAGs content, and C) sGAG/DNA ratio. Symbol # denote significant increase on day 7, 14 and 21 cultures. Symbols 
* denote a significant decrease in day 14 and 21 cultures. * # p<0.05. The value showed mean ± SEM, n=6
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increased in the expression gene of Aggrecan core protein, 
Type II collagen and Type X collagen and consistently 
expressed in Type I collagen (Liao et al. 2015; Ude et 
al. 2017). Meanwhile, the expression of elastin gene was 
higher in HADSC induced with TGF-β3 suggested that the 
chondrogenic differentiation of stem cells was occurred 
more with TGF-β3 has potential to differentiate stem 
cells into auricular chondrocyte. The level expression of 
Elastin was suggested that the production of elastin protein 
requires a longer period of cultures. Previous studies also 
reported that the bone marrow stem required 28 day of 
induction to express the high expression gene of Elastin 
(Cai et al. 2015; Zhang et al. 2015).
CONCLUSION
In conclusion, TGF-β3 were found have better 
chondrogenesis effect in terms of cell regulation, 
proliferation/cell viability, chondrogenic differentiation 
and production of extracellular matrix protein (ECM) in 
induced HADSC. The members of transformation growth 
factor, TGF-β3 has showed a better chondrogenesis 
FIGURE 5. Relative gene expression: A) Type II collagen, B) Elastin, C) Aggrecan core protein, D) Sox 9, E) Type I collagen, 
and F) Type X collagen in HADSC control (HAD), Human auricular chondrocyte control (NAU), HADSC induced with TGF-β1, 
TGF-β2 and TGF-β3 on day 7, 14 and 21 cultures. Symbol # denote a significant increase between culturing days. Symbols * 
denote a significant decrease between culturing days. * # p<0.05. The value shows the mean ± SEM, n = 6
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process than TGF-β1 and TGF-β2 in the chondrogenic 
differentiation wherein cell aggregation, ECM production, 
especially glycosaminoglycan and collagen Type II 
and expression of chondrogenic markers genes such as 
Collagen Type II, Elastin, Aggrecan core protein and Sox 
9. High expression gene of Elastin in HADSC induced 
TGF-β3 was suggested that TGF-β3 is better growth factor 
in HADSC differentiation into auricular chondrocyte 
compared to others. Additionally, the chondrogenic 
differentiation of HADSC by monocultures technique 
also exhibited dedifferentiation and hypertrophic 
differentiation characteristics whereas the expression of 
type I collagen and type X collagen were expressed during 
cell differentiation. Furthermore, the alternative culture 
technique need to explore to improve chondrogenic 
differentiation capacities of HADSC during culturing 
procedure for auricular reconstruction approach. 
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